Form D — Lycia Therapeutics, Inc.
0001806540-26-000001 · filed 2026-06-25
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $75,000,000
- Total sold
- $75,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Lycia Therapeutics, Inc.
- CIK
- 1806540
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 400 EAST JAMIE COURT, SUITE 200
SOUTH SAN FRANCISCO, CA 94080 - Phone
- (650) 392-3357
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
William Rieflin · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Clare Ozawa · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Ming Fang · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Laurent Fischer · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Tim Anderson · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Aetna Wun Trombley · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Amy Bachrodt · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
View original on SEC EDGAR.